Clinical Trial Update: Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST [Phase 4]

View source ↗

Summary

A Phase 4 trial update announcing initiation of first-line antiretroviral treatment with tenofovir alafenamide-emtricitabine-bictegravir at first clinical conta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TENOFOVIR ALAFENAMIDE EMTRICITABINE BICTEGRAVIR

Snippet

Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | Conditions: HIV Seropositivity | Phase 4 | Status: UNKNOWN